Results 31 to 40 of about 53,094 (317)

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results

open access: yesFrontiers in Oncology, 2013
Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani   +3 more
doaj   +1 more source

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation

open access: yesAdvances in Radiation Oncology, 2022
Purpose: Whole gland cryoablation is a guideline-approved definitive treatment for localized prostate cancer, and is being explored for partial gland ablation. However, there is limited data regarding management of cryoablation failures.
Jonathan W. Lischalk, MD   +9 more
doaj   +1 more source

Changing paradigm of radiation therapy for the treatment of pancreatic cancer

open access: yesPrecision Radiation Oncology, 2019
The evidence supporting the use of radiation therapy (RT) for pancreatic cancer (PC) treatment is highly variable, with studies both showing and failing to show that RT provides a survival benefit.
Beth K Neilsen, Chi Lin
doaj   +1 more source

The role of biological dose-escalation for pancreatic cancer

open access: yesClinical and Translational Radiation Oncology, 2019
The role of chemo-radiotherapy for treatment of locally advanced pancreatic cancer (LAPC) has been discussed for many years, and the absence of an overall survival benefit compared to gemcitabine chemotherapy alone in the recent LAP07 study seems to have
Anna M.E. Bruynzeel, Frank J. Lagerwaard
doaj   +1 more source

Proton beam radiotherapy in the management of uveal melanoma: clinical experience in Scotland [PDF]

open access: yes, 2008
<p>Aim: To evaluate proton-beam radiotherapy (PBRT) in the management of uveal melanoma in Scotland.</p> <p>Methods: A retrospective review was undertaken on all patients receiving PBRT for uveal melanoma (1994–2005).
Aziz, S.   +4 more
core   +3 more sources

Radiation Oncology Residency Training in Latin America: A Call to Attention

open access: yesAdvances in Radiation Oncology, 2022
Purpose: Despite the call to increase the number of radiation oncologists in Latin America, the quality, similarity, and number of residency training programs are unknown.
Benjamin Li, MD, MBA   +11 more
doaj   +1 more source

Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study

open access: yesRadiology and Oncology, 2021
The aim of the study was to evaluate acute side effects after extremely hypofractionated intensity-modulated radiotherapy (IMRT) with stereotactic body radiation therapy (SBRT) for definitive treatment of prostate cancer patients.
Jorgo Kliton   +5 more
doaj   +1 more source

Dosimetric validation of a magnetic resonance image gated radiotherapy system using a motion phantom and radiochromic film. [PDF]

open access: yes, 2017
PurposeMagnetic resonance image (MRI) guided radiotherapy enables gating directly on the target position. We present an evaluation of an MRI-guided radiotherapy system's gating performance using an MRI-compatible respiratory motion phantom and ...
Berbeco   +28 more
core   +1 more source

Spectrum of Imaging Patterns of Lung Cancer following Radiation Therapy

open access: yesDiagnostics, 2023
Radiation therapy using conventional or newer high-precision dose techniques, including three-dimensional conformal radiotherapy, intensity-modulated radiation therapy, stereotactic body radiation therapy, four-dimensional conformational radiotherapy ...
Taylor A. Strange   +6 more
doaj   +1 more source

A Patient‐Derived Organoid Biobank of Adamantinomatous Craniopharyngioma as a Platform for Drug Discovery

open access: yesAdvanced Science, EarlyView.
This study successfully establishes adamantinomatous craniopharyngioma (ACP) patient‐derived organoids (PDOs) that preserve the histopathological and genetic features of the original tumors. Through drug sensitivity assays and subsequent mechanistic analyses, the study demonstrates that Ceritinib exerts its inhibitory effects on ACP PDO growth by ...
Huarong Zhang   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy